Gautam Sethi
Molecular Biology · 2005–2023
A researcher in the Science corpus: 9 papers; trusts 1 researcher and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Molecular Biology — 151 citations into it
- Cancer Research — 53 citations into it
Whom Gautam Sethi trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Gautam Sethi overall
Papers from Gautam Sethi's perspective
Ordered by how strongly the researchers Gautam Sethi trusts endorse each paper. Same corpus, a different order for every researcher.
- The hallmarks of cancer (RNA Biology)
- Free radicals and antioxidants in normal physiological functions and human disease. (International Journal of Biochemistry and Cell Biology)
- Molecular targets of dietary agents for prevention and therapy of cancer. (Biochemical Pharmacology)
- Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. (Journal of the National Cancer Institute)
- NF-κB functions as a tumour promoter in inflammation-associated cancer (Nature)
- Targeting death and decoy receptors of the tumour-necrosis factor superfamily (Nature Reviews. Cancer)
- AKT/PKB signaling: navigating downstream. (Cell)
- Signalling pathways of the TNF superfamily: a double-edged sword (Nature reviews. Immunology)
- Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. (Anticancer Research)
- Matrix metalloproteinases: biologic activity and clinical implications. (Journal of Clinical Oncology)
Their papers
- Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. (2007) — 688 citations
- Inflammation and cancer: how hot is the link? (2006) — 1,379 citations
- The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges (2019) — 1,125 citations
- PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer (2023) — 1,782 citations
- Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and Recent Advancements (2019) — 985 citations
- The Role of Resveratrol in Cancer Therapy (2017) — 682 citations
- Targeting the STAT3 signaling pathway in cancer: role of synthetic and natural inhibitors. (2014) — 650 citations
- The Vascular Endothelium and Human Diseases (2013) — 1,375 citations
- Curcumin: Getting Back to the Roots (2005) — 737 citations